Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, January 8, 2021
[ Fri, Jan 08th 2021
] - WOPRAI
[ Fri, Jan 08th 2021
] - WOPRAI
Thu, January 7, 2021
[ Thu, Jan 07th 2021
] - WOPRAI
[ Thu, Jan 07th 2021
] - WOPRAI
[ Thu, Jan 07th 2021
] - WOPRAI
[ Thu, Jan 07th 2021
] - WOPRAI
[ Thu, Jan 07th 2021
] - WOPRAI
[ Thu, Jan 07th 2021
] - WOPRAI
[ Thu, Jan 07th 2021
] - WOPRAI
[ Thu, Jan 07th 2021
] - WOPRAI
[ Thu, Jan 07th 2021
] - WOPRAI
[ Thu, Jan 07th 2021
] - WOPRAI
[ Thu, Jan 07th 2021
] - WOPRAI
[ Thu, Jan 07th 2021
] - WOPRAI
[ Thu, Jan 07th 2021
] - WOPRAI
[ Thu, Jan 07th 2021
] - WOPRAI
[ Thu, Jan 07th 2021
] - WOPRAI
[ Thu, Jan 07th 2021
] - WOPRAI
[ Thu, Jan 07th 2021
] - WOPRAI
[ Thu, Jan 07th 2021
] - WOPRAI
[ Thu, Jan 07th 2021
] - WOPRAI
[ Thu, Jan 07th 2021
] - WOPRAI
[ Thu, Jan 07th 2021
] - WOPRAI
John Abbott Initiated (ARCT) at Buy on, Jan 7th, 2021
John Abbott of Wells Fargo, Initiated "Arcturus Therapeutics Holdings Inc." (ARCT) at Buy on, Jan 7th, 2021.
John has made no other calls on ARCT in the last 4 months.
There are 5 other peers that have a rating on ARCT. Out of the 5 peers that are also analyzing ARCT, 3 agree with John's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Ed Arce of "HC Wainwright & Co." Downgraded from Strong Buy to Hold and Decreased Target to $50 on, Tuesday, December 29th, 2020
- Madhu Kumar of "Baird" Downgraded from Buy to Hold and Decreased Target to $69 on, Tuesday, December 29th, 2020
- Steven Seedhouse of "Raymond James" Downgraded from Buy to Hold on, Tuesday, December 29th, 2020
These are the ratings of the 2 analyists that currently disagree with John
- Elemer Piros of "Roth Capital" Downgraded from Strong Buy to Strong Sell and Held Target at $77 on, Wednesday, December 23rd, 2020
- Yigal Nochomovitz of "Citigroup" Initiated at Strong Buy and Held Target at $65 on, Tuesday, October 6th, 2020
